nach oben

Current Treatment Options in Neurology

Erschienen in:

01.11.2019 | Pediatric Neurology (A Yeshokumar, Section Editor)

Transcranial Magnetic Stimulation for the Treatment of Pediatric Neurological Disorders

verfasst von: Laura A. Malone, MD, PhD, Lisa R. Sun, MD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Repetitive transcranial magnetic stimulation (rTMS) is a form of noninvasive brain stimulation that is used for the treatment of migraine and major depression in adults and is now being evaluated for use in other disorders. The purpose of this review is to summarize the physiology underlying TMS, the safety and tolerability in pediatric patients, and the evidence for TMS efficacy in the treatment of pediatric neurologic disorders.

Recent findings

Studies investigating rTMS for adolescent depression, hemiparesis due to pediatric stroke, autism, and tics/Tourette syndrome have demonstrated some therapeutic benefit. rTMS has been insufficiently studied for migraine in children despite benefits demonstrated for adult migraine. Evidence for rTMS in childhood epilepsy and ADHD remains mixed.

Summary

Repetitive transcranial magnetic stimulation is emerging as a safe, tolerable, and potentially effective therapeutic strategy in a number of pediatric neurological disorders, though high-quality, randomized controlled trials are needed. Ongoing studies should focus on optimization of treatment protocols, development of biomarkers to identify children who will benefit from the technique, and identification of the most appropriate indicators of response.

Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–7.PubMedCrossRef

Eldaief MC, Press DZ, Pascual-Leone A. Transcranial magnetic stimulation in neurology: a review of established and prospective applications. Neurol Clin Pract. 2013;3:519–26.PubMedPubMedCentralCrossRef

Schwedt TJ, Vargas B. Neurostimulation for treatment of migraine and cluster headache. Pain Med. 2015;16:1827–34.PubMedCrossRef

Hameed MQ, Dhamne SC, Gersner R, Kaye HL, Oberman LM, Pascual-Leone A, et al. Transcranial magnetic and direct current stimulation in children. Curr Neurol Neurosci Rep. 2017;17:11.PubMedPubMedCentralCrossRef

Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003;2:145–56.PubMedCrossRef

Narayana S, Papanicolaou AC, McGregor A, Boop FA, Wheless JW. Clinical applications of transcranial magnetic stimulation in pediatric neurology. J Child Neurol. 2015;30:1111–24.PubMedCrossRef

Allen CH, Kluger BM, Buard I. Safety of transcranial magnetic stimulation in children: a systematic review of the literature. Pediatr Neurol. 2017;68:3–17.PubMedPubMedCentralCrossRef

Huang Y-Z, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005;45:201–6.PubMedCrossRef

Eyre JA, Taylor JP, Villagra F, Smith M, Miller S. Evidence of activity-dependent withdrawal of corticospinal projections during human development. Neurology. 2001;57:1543–54.PubMedCrossRef

10.

Eyre JA, Smith M, Dabydeen L, Clowry GJ, Petacchi E, Battini R, et al. Is hemiplegic cerebral palsy equivalent to amblyopia of the corticospinal system? Ann Neurol. 2007;62:493–503.PubMedCrossRef

11.

Sun W, Mao W, Meng X, Wang D, Qiao L, Tao W, et al. Low-frequency repetitive transcranial magnetic stimulation for the treatment of refractory partial epilepsy: a controlled clinical study. Epilepsia. 2012;53:1782–9.PubMedCrossRef

12.

Garvey MA, Kaczynski KJ, Becker DA, Bartko JJ. Subjective reactions of children to single-pulse transcranial magnetic stimulation. J Child Neurol. 2001;16:891–4.PubMedCrossRef

13.

Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75:477–89 quiz 489.PubMedCrossRef

14.

Horvath JC, Mathews J, Demitrack MA, Pascual-Leone A. The NeuroStar TMS device: conducting the FDA approved protocol for treatment of depression. J Vis Exp. 2010.

15.

Koenigs M, Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res. 2009;201:239–43.PubMedPubMedCentralCrossRef

16.

Yang X-R, Kirton A, Wilkes TC, Pradhan S, Liu I, Jaworska N, et al. Glutamate alterations associated with transcranial magnetic stimulation in youth depression: a case series. J ECT. 2014;30:242–7.PubMedCrossRef

17.

Wall CA, Croarkin PE, Sim LA, Husain MM, Janicak PG, Kozel FA, et al. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry. 2011;72:1263–9.PubMedCrossRef

18.

•• MacMaster FP, Croarkin PE, Wilkes TC, McLellan Q, Langevin LM, Jaworska N, et al. Repetitive transcranial magnetic stimulation in youth with treatment resistant major depression. Front Psychiatry. 2019;10:170. In this study of 32 adolescents and young adults (ages 13–21) with treatment-resistant major depressive disorder, rTMS over the left DLPFC for 15 consecutive weekdays resulted in clinically significant improvement in symptom severity in 56% of subjects. PubMedPubMedCentralCrossRef

19.

Donaldson AE, Gordon MS, Melvin GA, Barton DA, Fitzgerald PB. Addressing the needs of adolescents with treatment resistant depressive disorders: a systematic review of rTMS. Brain Stimul. 2014;7:7–12.PubMedCrossRef

20.

Zhang T, Zhu J, Xu L, Tang X, Cui H, Wei Y, et al. Add-on rTMS for the acute treatment of depressive symptoms is probably more effective in adolescents than in adults: evidence from real-world clinical practice. Brain Stimul. 2019;12:103–9.PubMedCrossRef

21.

Mayer G, Aviram S, Walter G, Levkovitz Y, Bloch Y. Long-term follow-up of adolescents with resistant depression treated with repetitive transcranial magnetic stimulation. J ECT. 2012;28:84–6.PubMedCrossRef

22.

Bloch Y, Grisaru N, Harel EV, Beitler G, Faivel N, Ratzoni G, et al. Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. J ECT. 2008;24:156–9.PubMedCrossRef

23.

Wall CA, Croarkin PE, McClintock SM, Murphy LL, Bandel LA, Sim LA, et al. Neurocognitive effects of repetitive transcranial magnetic stimulation in adolescents with major depressive disorder. Front Psychiatry. 2013;4:165.PubMedPubMedCentralCrossRef

24.

Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.PubMedCrossRef

25.

Kalita J, Laskar S, Bhoi SK, Misra UK. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol. 2016;263:2238–46.PubMedCrossRef

26.

Misra UK, Kalita J, Bhoi SK. High frequency repetitive transcranial magnetic stimulation (rTMS) is effective in migraine prophylaxis: an open labeled study. Neurol Res. 2012;34:547–51.PubMedCrossRef

27.

Shirahige L, Melo L, Nogueira F, Rocha S, Monte-Silva K. Efficacy of noninvasive brain stimulation on pain control in migraine patients: a systematic review and meta-analysis. Headache. 2016;56:1565–96.PubMedCrossRef

28.

Lan L, Zhang X, Li X, Rong X, Peng Y. The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails. J Headache Pain. 2017;18:86.PubMedPubMedCentralCrossRef

29.

Wang T, Huang L, Xu H, Yan L, Wu Q, Shen F, et al. Seizure induced by repetitive transcranial magnetic stimulation in an adolescent with migraine with aura. Brain Stimul. 2018;11:1380–1.PubMedCrossRef

30.

Stinear C, Ackerley S, Byblow W. Rehabilitation is initiated early after stroke, but most motor rehabilitation trials are not: a systematic review. Stroke. 2013;44:2039–45.PubMedCrossRef

31.

Ward NS, Cohen LG. Mechanisms underlying recovery of motor function after stroke. Arch Neurol. 2004;61:1844–8.PubMedPubMedCentralCrossRef

32.

Murase N, Duque J, Mazzocchio R, Cohen LG. Influence of interhemispheric interactions on motor function in chronic stroke. Ann Neurol. 2004;55:400–9.PubMedCrossRef

33.

Hoyer EH, Celnik PA. Understanding and enhancing motor recovery after stroke using transcranial magnetic stimulation. Restor Neurol Neurosci. 2011;29:395–409.PubMedPubMedCentral

34.

Boddington LJ, Reynolds JNJ. Targeting interhemispheric inhibition with neuromodulation to enhance stroke rehabilitation. Brain Stimul. 2017;10:214–22.PubMedCrossRef

35.

Xu J, Branscheidt M, Schambra H, Steiner L, Widmer M, Diedrichsen J, et al. Rethinking interhemispheric imbalance as a target for stroke neurorehabilitation. Ann Neurol. 2019;85:502–13.PubMedCrossRefPubMedCentral

36.

Hsu W-Y, Cheng C-H, Liao K-K, Lee I-H, Lin Y-Y. Effects of repetitive transcranial magnetic stimulation on motor functions in patients with stroke: a meta-analysis. Stroke. 2012;43:1849–57.PubMedCrossRef

37.

Kirton A, Chen R, Friefeld S, Gunraj C, Pontigon A-M, Deveber G. Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial. Lancet Neurol. 2008;7:507–13.PubMedCrossRef

38.

Gillick BT, Krach LE, Feyma T, Rich TL, Moberg K, Thomas W, et al. Primed low-frequency repetitive transcranial magnetic stimulation and constraint-induced movement therapy in pediatric hemiparesis: a randomized controlled trial. Dev Med Child Neurol. 2014;56:44–52.PubMedCrossRef

39.

Eliasson A-C, Bonnier B, Krumlinde-Sundholm L. Clinical experience of constraint induced movement therapy in adolescents with hemiplegic cerebral palsy--a day camp model. Dev Med Child Neurol. 2003;45:357–9.PubMedCrossRef

40.

•• Kirton A, Andersen J, Herrero M, Nettel-Aguirre A, Carsolio L, Damji O, et al. Brain stimulation and constraint for perinatal stroke hemiparesis: the PLASTIC CHAMPS Trial. Neurology. 2016;86:1659–67. The PLASTIC CHAMPS trial randomized 45 children and adolescents ages 6–19 years with hemiparetic cerebral palsy as a result of a perinatal stroke to intensive motor therapy (80 h of therapy over 2 weeks) alone or in combination with low-frequency (inhibitory) rTMS of the contralesional primary motor cortex, constraint-induced movement therapy (CIMT), or both. Addition of rTMS or CIMT to intensive therapy doubled the chances of clinically significant improvement as measured by the assisting hand assessment, with an additive effect when both treatment modalities were used together. Sustained functional gains were demonstrated after 6 months; however, they did gradually decrease over time.PubMedPubMedCentralCrossRef

41.

Hsu W-Y, Cheng C-H, Lin M-W, Shih Y-H, Liao K-K, Lin Y-Y. Antiepileptic effects of low frequency repetitive transcranial magnetic stimulation: a meta-analysis. Epilepsy Res. 2011;96:231–40.PubMedCrossRef

42.

Rotenberg A, Bae EH, Takeoka M, Tormos JM, Schachter SC, Pascual-Leone A. Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua. Epilepsy Behav. 2009;14:253–7.PubMedCrossRef

43.

Graff-Guerrero A, Gonzáles-Olvera J, Ruiz-García M, Avila-Ordoñez U, Vaugier V, García-Reyna JC. rTMS reduces focal brain hyperperfusion in two patients with EPC. Acta Neurol Scand. 2004;109:290–6.PubMedCrossRef

44.

Rejnö-Habte Selassie G, Pegenius G, Viggedal G, Hallböök T, Thordstein M. Navigated transcranial magnetic stimulation for preoperative cortical mapping of expressive language in children: development of a method. Epilepsy Behav. 2018;87:180–7.PubMedCrossRef

45.

Säisänen L, Könönen M, Julkunen P, Määttä S, Vanninen R, Immonen A, et al. Non-invasive preoperative localization of primary motor cortex in epilepsy surgery by navigated transcranial magnetic stimulation. Epilepsy Res. 2010;92:134–44.PubMedCrossRef

46.

Grados M, Huselid R, Duque-Serrano L. Transcranial magnetic stimulation in Tourette syndrome: a historical perspective, its current use and the influence of comorbidities in treatment response. Brain Sci. 2018;8.

47.

Le K, Liu L, Sun M, Hu L, Xiao N. Transcranial magnetic stimulation at 1 hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months. J Clin Neurosci. 2013;20:257–62.PubMedCrossRef

48.

Orth M, Kirby R, Richardson MP, Snijders AH, Rothwell JC, Trimble MR, et al. Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome. Clin Neurophysiol. 2005;116:764–8.PubMedCrossRef

49.

Münchau A, Bloem BR, Thilo KV, Trimble MR, Rothwell JC, Robertson MM. Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology. 2002;59:1789–91.PubMedCrossRef

50.

Kwon HJ, Lim WS, Lim MH, Lee SJ, Hyun JK, Chae J-H, et al. 1-Hz low frequency repetitive transcranial magnetic stimulation in children with Tourette’s syndrome. Neurosci Lett. 2011;492:1–4.PubMedCrossRef

51.

Bloch Y, Arad S, Levkovitz Y. Deep TMS add-on treatment for intractable Tourette syndrome: a feasibility study. World J Biol Psychiatry. 2016;17:557–61.PubMed

52.

Gilbert DL, Isaacs KM, Augusta M, Macneil LK, Mostofsky SH. Motor cortex inhibition: a marker of ADHD behavior and motor development in children. Neurology. 2011;76:615–21.PubMedPubMedCentralCrossRef

53.

Weaver L, Rostain AL, Mace W, Akhtar U, Moss E, O’Reardon JP. Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study. J ECT. 2012;28:98–103.PubMedCrossRef

54.

Paz Y, Friedwald K, Levkovitz Y, Zangen A, Alyagon U, Nitzan U, et al. Randomised sham-controlled study of high-frequency bilateral deep transcranial magnetic stimulation (dTMS) to treat adult attention hyperactive disorder (ADHD): negative results. World J Biol Psychiatry. 2018;19:561–6.PubMedCrossRef

55.

Finisguerra A, Borgatti R, Urgesi C. Non-invasive brain stimulation for the rehabilitation of children and adolescents with neurodevelopmental disorders: a systematic review. Front Psychol. 2019;10:135.PubMedPubMedCentralCrossRef

56.

Barahona-Corrêa JB, Velosa A, Chainho A, Lopes R, Oliveira-Maia AJ. Repetitive transcranial magnetic stimulation for treatment of autism spectrum disorder: a systematic review and meta-analysis. Front Integr Neurosci. 2018;12:27.PubMedPubMedCentralCrossRef

57.

Moussavi Z, Suleiman A, Rutherford G, Ranjbar Pouya O, Dastgheib Z, Zhang W, et al. A pilot randomised double-blind study of the tolerability and efficacy of repetitive transcranial magnetic stimulation on persistent post-concussion syndrome. Sci Rep. 2019;9:5498.PubMedPubMedCentralCrossRef

58.

Parain D, Chastan N. Large-field repetitive transcranial magnetic stimulation with circular coil in the treatment of functional neurological symptoms. Neurophysiol Clin. 2014;44:425–31.PubMedCrossRef

59.

Pollak TA, Nicholson TR, Edwards MJ, David AS. A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. J Neurol Neurosurg Psychiatry. 2014;85:191–7.PubMedCrossRef

60.

Garcin B, Roze E, Mesrati F, Cognat E, Fournier E, Vidailhet M, et al. Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders. J Neurol Neurosurg Psychiatry. 2013;84:1043–6.PubMedCrossRef

61.

Lai J-B, Han M-M, Xu Y, Hu S-H. Effective treatment of narcolepsy-like symptoms with high-frequency repetitive transcranial magnetic stimulation: a case report. Medicine (Baltimore). 2017;96:e8645.CrossRef

62.

Mylius V, Gerstner A, Peters M, Prokisch H, Leonhardt A, Hellwig D, et al. Low-frequency rTMS of the premotor cortex reduces complex movement patterns in a patient with pantothenate kinase-associated neurodegenerative disease (PKAN). Neurophysiol Clin. 2009;39:27–30.PubMedCrossRef

Titel: Transcranial Magnetic Stimulation for the Treatment of Pediatric Neurological Disorders
verfasst von: Laura A. Malone, MD, PhD
Lisa R. Sun, MD
Publikationsdatum: 01.11.2019
Verlag: Springer US
Erschienen in: Current Treatment Options in Neurology / Ausgabe 11/2019
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI: https://doi.org/10.1007/s11940-019-0600-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of review

Recent findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Therapies for Restless Legs in Parkinson’s Disease

Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy

Functional Electrical Stimulation Cycling Exercise for People with Multiple Sclerosis

Brain Metastases as a First Site of Recurrence in Patients Receiving Chemotherapy with Controlled Systemic Cancer: a Critical but Under-Recognized Clinical Scenario